Italy’s Biofarma Group – which specializes in the development, manufacturing and packaging of food supplements, medical devices and cosmetics – has new private-equity owners. Paris, France-based Ardian has acquired a majority stake in Biofarma from White Bridge Investments for €1.1bn ($1.2bn).
Founders the Scarpa family will retain a 30% stake in Biofarma, with CEO Maurizio